Clin2
NCT07281950Likely a fitNot yet recruiting

Dry eye treatment study with acoltremon

Dry Eye Disease (DED)

Treatments studied

Part of Eyes & vision clinical trials.

This study tests an FDA-approved dry eye treatment called acoltremon. We want to see if it helps people with dry eye disease feel better. You will answer surveys about your symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have had dry eye for at least 3 months
  • Your dry eye symptoms score at least 6 on the SPEED questionnaire
  • You have not had eye surgery in the past 3 months, and no LASIK or PRK in the past 12 months
  • You have not used certain dry eye drops or medications in the past 30 days
  • You are not pregnant, breastfeeding, or planning to become pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07268599Enrolling by invitation
Acoltremon for moderate-to-severe dry eye relief

This study tests a new eye drop called Acoltremon to see if it can relieve symptoms of moderate-to-severe dry eye disease. It may be a good option if you have had dry eye for at least 6 months and use artificial tears.

Encino, California
NCT07732010Recruiting· Phase 4
Tryptophan for dry eye disease

This trial tests whether a dietary supplement called TRYPTYR can improve dry eye symptoms. You may qualify if you have moderate dry eye with certain signs, like short tear breakup time and staining on your eye surface.

New York, New York
NCT06879782Recruiting· Phase 3
Eye drops for dry eye disease: a phase 3 study

This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.

Beijing, Beijing Municipality
NCT07503886Recruiting· Phase 2
Study of an eye drop for dry eye disease

This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.

Chandler, Arizona
NCT07068958Not yet recruiting· Phase 2
A study testing a new eye drop for dry eye

This trial tests a new eye drop called RCI001 to see if it works better than a placebo for people with dry eye. You may be able to join if you have had dry eye for at least 6 months and have certain signs of dry eye during exams.

NCT06633471Not yet recruiting· Early Phase 1
Evaluating a new artificial tear for dry eye disease

This study tests a new eye drop formula to see if it safely improves dry eye symptoms. It may be a good option if you have been diagnosed with dry eye and have limited tear production.

Bridgetown

Hear when a new Dry Eye Disease (DED) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.